Sonoma Pharmaceuticals
SNOA
#10421
Rank
โ‚ฌ4.16 M
Marketcap
2,41ย โ‚ฌ
Share price
-0.18%
Change (1 day)
6.01%
Change (1 year)

EPS for Sonoma Pharmaceuticals (SNOA)

EPS in 2025 (TTM): -2,05ย โ‚ฌ

According to Sonoma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,95ย โ‚ฌ. In 2018 the company made an earnings per share (EPS) of -334,06ย โ‚ฌ an increase over its 2017 EPS that were of -426,67ย โ‚ฌ.

EPS history for Sonoma Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,05ย โ‚ฌ
2018-334,06ย โ‚ฌ-21.7%
2017-426,67ย โ‚ฌ-241.62%
2016301,27ย โ‚ฌ-170.36%
2015-428,20ย โ‚ฌ-354.55%
2014168,22ย โ‚ฌ-122.01%
2013-764,34ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
-0,20ย โ‚ฌ-89.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-0,81ย โ‚ฌ-58.70%๐Ÿ‡บ๐Ÿ‡ธ USA